Screener
Ionis Pharmaceuticals IONS Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
FAQ
- What is Ionis Pharmaceuticals's asset turnover?
- Ionis Pharmaceuticals (IONS) reported asset turnover of 0.3× in Q2 2026.
- How has Ionis Pharmaceuticals's asset turnover changed year-over-year?
- Ionis Pharmaceuticals's asset turnover decreased by 12.1% year-over-year, from 0.3× to 0.3×.
- What is the long-term trend for Ionis Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's asset turnover has grown at a 2.2% compound annual growth rate (CAGR), from 0.3× to 0.3×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Ionis Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude